Origin |
Artificially produced from a wide variety of phospholipids |
Secreted by cells |
Shape and size |
Phospholipid bilayer structures; ~100 nm and homogenous |
Phospholipid bilayer structures including many proteins (e.g., tetraspanins); 30-120 nm |
Manufacture |
Many manufacturing possibilities |
No current manufacturing methods |
Contents |
Single component |
Complex components (e.g., DNA, RNA, proteins, small molecule drugs) |
Drug loading capacity |
High loading of hydrophilic drugs |
Low drug loading |
Half-life |
10-55 h |
70-80 min |
Targeted delivery |
Poor and dependent on the enhanced permeability and retention (EPR) effect |
Strong with ability to cross biological membranes and high endogenous targeting potential |